Hepa Wash GmbH: Liver, kidney and lung support integrated in a single system

Hepa Wash is a medical technology company that has developed a novel liver sup­­port therapy for patients suffering from life threatening liver failure.

If the liver’s detoxification capability is impaired, a severe progression of the dis­­ease with multiple organ failure may occur. To combat the situation, the Hepa Wash® procedure offers a reliable and ef­­fective form of treatment. Integrated into one sys­tem, both liver and kidney toxins can be removed from the patient’s blood and the pulmonary function can be supported.

Hepa Wash GmbH was founded in Munich in 2005 as a one-man start-up. The purpose of its inception was to independently develop and realize an effective liver sup­port ther­­apy beginning with the concept up to the end-user marketability. Today, the company employs a highly diversified team consisting of more than 25 employees, who cover all re­­levant sectors needed to commercialize the proce­dure – from research & development, through regulatory affairs and production to service and application consulting.

The Hepa Wash® therapy was granted ap­­proval for the European market in 2013. The company is working in cooperation with leading universities and univer­sity hospitals in Bavaria to continuously promote the research and development of additional therapeutic options.



  1. Address

    Agnes-Pockels-Bogen 1
    (Münchner Technologie Zentrum)
    80992 München
    Tel +49 89 4111 842-0
    Fax +49 89 4111 842-09

  2. Management

    PD Dr. Bernhard Kreymann

  3. Year of establishment


  4. Employees

    25+ (supervision of
    ten student degree theses on average annually)

  5. Business activity

    Production & commercialization of liver support devices and
    accessories, QM-certified according to EN ISO 13485 & MDD 93/42 EEC Annex II.3